Nkarta Inc (NKTX)

$7.40 0.13 (1.73%)

16:00 EDT NKTX Stock Quote Delayed 30 Minutes

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

By William White, InvestorPlace Writer Mar 25, 2024

We are starting off the day with a breakdown of the biggest pre-market stock movers that traders need to know about on Monday morning.

NKTX Stock Earnings: Nkarta Beats EPS for Q4 2023

3 Overlooked Stocks Ready to Capture the Market by Storm

3 Silent Tech Titans-in-the-Making: Invest Before They Skyrocket

Volume:

Previous Close -

Market Cap 362.12M

PE Ratio -11.75

EPS -0.63

Volume (Avg. Vol.) 820,345

Day's Range $7.35 - $8.33

52-Week Range $1.28 - $16.24

Dividend & Yield N/A (N/A)

NKTX Stock Predictions, Articles, and Nkarta Inc News

From InvestorPlace
From the Web

Last Call! 7 Small-Cap Stocks Ready to Explode in Value

By Yiannis Zourmpanos, InvestorPlace Contributor Feb 20, 2024

For those looking for opportunities that promise exponential return potential, the article lists seven small-cap stocks.

3 Under-the-Radar Stocks Set to Soar 300% by 2026

By Yiannis Zourmpanos, InvestorPlace Contributor Feb 8, 2024

Uncover the potential of three under-the-radar stocks for 300% growth by 2026, spanning tech, biotech and energy sectors.

3 Sleeper Stocks With Serious Potential to Make You a Millionaire

By Chandler Capital, InvestorPlace Contributor Feb 6, 2024

Investors might miss these under-the-radar stocks and miss out on gains. Here are three sleeper companies with millionaire potential.

3 Once-in-a-Lifetime Biotech Stocks With Unprecedented Surge Potential

By Gabriel Osorio-Mazzilli, InvestorPlace Contributor Feb 5, 2024

As the new business cycle gets started, here are some biotech stocks with potential that investors should pay attention to.

Unseen Giants: 3 Stocks Quietly Preparing for a 10X Surge

By Yiannis Zourmpanos, InvestorPlace Contributor Feb 4, 2024

These companies, spanning the semiconductor, healthcare and biotechnology sectors, are emerging as unseen giants with the potential for a 10X surge.

3 Promising Biotech Stocks That Will Make Early Investors Rich

By Josh Enomoto, InvestorPlace Contributor Oct 2, 2023

Despite their volatility, certain biotech stocks stand out for their innovative approaches and potential game-changing therapies.

3 Hidden Penny Stocks That Could Turn $100 into $10,000

By Omor Ibne Ehsan Jul 31, 2023

These penny stocks have multibagger upside potential with great margins of safety, according to Wall Street analysts.

7 Stocks With Promising Upside Potential for 100% Returns

By Josh Enomoto, InvestorPlace Contributor May 7, 2023

If you still want to gamble even during this market environment, these are the stocks with 100% upside potential.

3 Biotech Stocks to Watch for Potential Breakthroughs

By Alex Sirois, InvestorPlace Contributor Apr 11, 2023

These biotech stocks have significant upside and realistic breakthrough chances in the current and distant future.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

By William White, InvestorPlace Writer Dec 5, 2022

The biggest pre-market stock movers for Monday include many Chinese shares that traders will want to keep an eye on today!

7 Unknown Biotech Stocks That Could Rocket in 2023

By Faisal Humayun, InvestorPlace Contributor Sep 23, 2022

Unknown biotech stocks that are poised for a big rally in 2023. Emerging biotech companies with a promising clinical pipeline.

Positive Clinical Results Put Nkarta Stock on the Fast Track

By Louis Navellier and the InvestorPlace Research Staff May 9, 2022

NKTX stock is a fast mover, and a recent share-price bump came in the wake of exciting data from a "killer cell" anti-cancer research program.

Why Is Nkarta (NKTX) Stock Soaring 90% Today?

By William White, InvestorPlace Writer Apr 25, 2022

Nkarta (NKTX) stock is rocketing higher on Monday after the company released preliminary data from a Phase 1 clinical trial.

Nkarta IPO: 13 Things for Potential NKTX Stock Investors to Know

By William White, InvestorPlace Writer Jul 10, 2020

The Nkarta (NKTX) IPO is underway for the cancer research company and it has it offering 14 million shares on the Nasdaq.

Promising Biopharma Nkarta (NASDAQ:NKTX) Not For the Faint-Hearted

From TipRanks Mar 26, 2024

Investors interested in clinical-stage biopharmaceutical companies like Nkarta (NASDAQ:NKTX) are often in a dilemma due to the uncertainty related to drug developme...

Nkarta says chief medical officer Shook sells 3.6K shares in co (NASDAQ:NKTX)

From Seeking Alpha Jan 19, 2024

Nkarta's chief medical officer, David Shook, sells 3.6K shares in the company to satisfy tax obligations.

Nkarta upgraded to strong buy by Raymond James (NKTX)

From Seeking Alpha Oct 17, 2023

Raymond James upgraded Nkarta (NKTX) to a strong buy on Tuesday, citing positive pipeline reprioritizations and an extended cash runway. Read more here.

Nkarta stock soars 112% amid FDA okay, cash runway extension (NKTX)

From Seeking Alpha Oct 17, 2023

Nkarta shares soared 112% following news that the FDA had cleared Phase 1 testing for its lupus drug candidate and that it cutting costs to extend its cash runway into 2026.

Nkarta stock jumps 20% on FDA, cash runway updates (NKTX)

From Seeking Alpha Oct 17, 2023

Nkarta shares jumped 20% following news that the FDA had cleared Phase 1 testing for its lupus drug candidate and that it cutting costs to extend its cash runway into 2026.

Why Shares of Nkarta Are Slumping Tuesday

From The Motley Fool Jun 27, 2023

The pharmaceutical stock dropped after announcing so-so clinical trial results.

Nkarta Inc (NKTX)

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

NKTX Stock Earnings: Nkarta Beats EPS for Q4 2023

3 Overlooked Stocks Ready to Capture the Market by Storm

3 Silent Tech Titans-in-the-Making: Invest Before They Skyrocket

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

Nkarta Inc (NKTX)

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

NKTX Stock Predictions, Articles, and Nkarta Inc News

Subscriber Sign in